1. Home
  2. PASW vs PLUR Comparison

PASW vs PLUR Comparison

Compare PASW & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PASW

Ping An Biomedical Co. Ltd. Ordinary Shares

HOLD

Current Price

$0.12

Market Cap

16.7M

ML Signal

HOLD

Logo Pluri Inc.

PLUR

Pluri Inc.

HOLD

Current Price

$1.36

Market Cap

18.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PASW
PLUR
Founded
2021
2001
Country
Hong Kong
Israel
Employees
7
N/A
Industry
Apparel
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.7M
18.5M
IPO Year
2021
2001

Fundamental Metrics

Financial Performance
Metric
PASW
PLUR
Price
$0.12
$1.36
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
11.4M
22.8K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.78
EPS
N/A
N/A
Revenue
N/A
$1,336,000.00
Revenue This Year
N/A
$97.38
Revenue Next Year
N/A
$293.97
P/E Ratio
N/A
N/A
Revenue Growth
N/A
309.82
52 Week Low
$0.11
$1.38
52 Week High
$1.08
$5.17

Technical Indicators

Market Signals
Indicator
PASW
PLUR
Relative Strength Index (RSI) 46.40 35.57
Support Level $0.13 N/A
Resistance Level $0.14 $1.85
Average True Range (ATR) 0.02 0.12
MACD 0.00 -0.01
Stochastic Oscillator 11.67 4.35

Price Performance

Historical Comparison
PASW
PLUR

About PASW Ping An Biomedical Co. Ltd. Ordinary Shares

Ping An Biomedical Co Ltd formerly Majestic Ideal Holdings Ltd is a Cayman Islands-based holding company, conducting operations through its PRC subsidiary, NewBrand. The group is a provider of SCM services in the apparel industry, offering solutions for a broad range of yarn products, textiles, and finished garments. Its service offerings encompass every key aspect of the supply chain of textile products, such as market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The group has two reportable segments, yarns and finished garments. The majority of its revenue is generated from the sale of yarns, including pure cashmere and cashmere-mix yarn, merino wool, cotton, and fancy yarn.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Share on Social Networks: